Voyager Therapeutics (VYGR) Times Interest Earned (2014 - 2026)
Voyager Therapeutics (VYGR) posted Times Interest Earned of -$0.75 for Q1 2026, down 266.16% sequentially from -$0.21 in Q4 2025, and up 96.85% YoY from -$0.38 in Q1 2025.
Voyager Therapeutics (VYGR) Times Interest Earned (2014 - 2026) Analysis & Trends
Voyager Therapeutics has reported Times Interest Earned for 13 years, with the latest figure at -$0.75 in Q1 2026.
- Quarterly Times Interest Earned rose 96.85% year-over-year to -$0.75 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.17 (up 95.47% YoY) and the FY2025 annual result came in at -$0.91, down 15.28% from the prior year.
- Times Interest Earned retreated to -$0.75 in Q1 2026 per VYGR's latest filing, from -$0.21 in the prior quarter.
- Over five years, Times Interest Earned peaked at $11.56 in Q1 2023 and troughed at -$30.61 in Q4 2024.
- A 5-year average of -$3.59 and a median of -$0.91 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned jumped 691.06% in 2022, then sank 4778.14% in 2024.
- Over 5 years, Times Interest Earned stood at -$0.21 in 2022, then surged by 412.78% to $0.65 in 2023, then tumbled by 4778.14% to -$30.61 in 2024, then jumped by 99.33% to -$0.21 in 2025, then plunged by 266.16% to -$0.75 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$0.75, -$0.21, and -$3.83 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Voyager Therapeutics | 205.86 Mn | 89.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.70 |
| Mar 31, 2026 | -0.75 |
| Dec 31, 2025 | -0.21 |
| Sep 30, 2025 | -3.83 |
| Jun 30, 2025 | -0.77 |
| Mar 31, 2025 | -23.89 |
| Dec 31, 2024 | -30.61 |
| Sep 30, 2024 | -3.67 |
| Jun 30, 2024 | -1.58 |
| Mar 31, 2024 | -0.91 |
| Dec 31, 2023 | 0.65 |
| Sep 30, 2023 | -3.16 |
| Jun 30, 2023 | -0.85 |
| Mar 31, 2023 | 11.56 |
| Dec 31, 2022 | -0.21 |
| Sep 30, 2022 | 2.54 |
| Jun 30, 2022 | -3.27 |
| Mar 31, 2022 | -2.12 |
| Dec 31, 2021 | 518.36 |
| Sep 30, 2021 | -0.43 |